STOCK TITAN

Planet Labs PBC (PL) Financials

PL
Trailing 12 months to July 31, 2026
Revenue $378.3M +44.1% YoY
Net Income -$359.9M -297.8% YoY
EPS (Diluted) -$1.11 -270.0% YoY
Free Cash Flow $24.7M -30.0% YoY
Market Cap $6.4B as of Oct 3, 2026
Price / Sales 16.8x on $378.3M revenue, trailing 12 months to July 31, 2026
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to July 31, 2026
Price / Book 11.3x on $564.4M equity, Q2 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2027, ended Jul 31, 2026 Reported Currency USD FYE January

Newest figures come from the 10-Q for Q2 FY2027, filed Sep 3, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PL SEC filings page.

Planet Labs PBC (PL) reported $378.3M in revenue over the twelve months to Jul 31, 2026, up 44.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PL FY2026

Planet Labs shifted from persistent cash consumption to positive free cash flow, while balance-sheet expansion sharply increased leverage.

In FY2026, operating cash flow turned positive at $134M while net income was a loss of $247M, so accounting results and cash movement sharply diverged. Because free cash flow was also positive at $57.6M despite capital expenditures of $76.7M, the year's cash result reflected cash generation exceeding reinvestment rather than simply reduced spending.

Gross margin expansion from 36.8% in FY2022 to 56.1% in FY2026 indicates the revenue base is carrying more gross profit. Operating margin also improved to -30.9% in FY2026, but operating costs still absorb that gross profit rather than convert it into operating earnings.

Assets rose to $1.15B in FY2026 while liabilities reached $957M, signaling a much more liability-funded balance sheet. Equity fell to $188M and debt-to-equity reached 5.1x, making the financing structure materially more leveraged.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 59 / 100
Financial Health Score 59/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Planet Labs PBC's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
86

Planet Labs PBC held $640.1M in cash, cash equivalents and investments at the end of fiscal year 2026, and its operations generated $134.4M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Planet Labs PBC scores 86/100 among other emerging companies.

Dilution
0

Not available for Planet Labs PBC, and counted as zero in the overall score.

R&D Intensity
59

Planet Labs PBC spent $106.7M on research and development in fiscal year 2026, which was 26.5% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Planet Labs PBC scores 59/100 among other emerging companies.

Revenue Progress
62

Planet Labs PBC reported revenue of $307.7M in fiscal year 2026, against $244.4M in fiscal year 2025. Revenue Progress ranks emerging companies on the three-year path of that line, and Planet Labs PBC scores 62/100 among other emerging companies.

Burn Trend
98

Planet Labs PBC's operations generated $134.4M of cash in fiscal year 2026, against $14.4M used in fiscal year 2025. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Planet Labs PBC scores 98/100 among other emerging companies.

Balance Sheet
50

Planet Labs PBC's cash, cash equivalents and investments came to $640.1M at the end of fiscal year 2026, against $957.3M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Planet Labs PBC scores 50/100 among other emerging companies.

Altman Z-Score Grey Zone
2.53

Planet Labs PBC scores 2.53, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($6.4B) relative to total liabilities ($957.3M). This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
2/7

Planet Labs PBC passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Mixed
N/A

Planet Labs PBC reported a net loss of $246.9M while generating $134.4M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Planet Labs PBC reported an operating loss of $95.1M against $3.4M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$116.1M
YoY+58.1%
QoQ+23.3%
5Y CAGR+30.7%

Planet Labs PBC generated $116.1M in revenue in Q2 2027. This represents an increase of 58.1% from the same quarter a year earlier. Against the prior quarter it is up 23.3%.

EBITDA
-$4.0M
YoY+50.3%
QoQ+83.1%

Planet Labs PBC's EBITDA was -$4.0M in Q2 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 50.3% from the same quarter a year earlier. Against the prior quarter it is up 83.1%.

Net Income
-$9.4M
YoY+58.6%
QoQ+93.3%

Planet Labs PBC reported -$9.4M in net income in Q2 2027. This represents an increase of 58.6% from the same quarter a year earlier. Against the prior quarter it is up 93.3%.

EPS (Diluted)
-$0.03
YoY+57.1%
QoQ+92.5%

Planet Labs PBC earned -$0.03 per diluted share (EPS) in Q2 2027. This represents an increase of 57.1% from the same quarter a year earlier. Against the prior quarter it is up 92.5%.

Cash & Balance Sheet

Free Cash Flow
$25.6M
YoY-46.1%
QoQ+1469.1%

Planet Labs PBC generated $25.6M in free cash flow in Q2 2027, representing cash available after capex. This represents a decrease of 46.1% from the same quarter a year earlier. Against the prior quarter it is up 1469.1%.

Cash & Debt
$415.1M
YoY+129.2%
QoQ+12.8%
5Y CAGR+38.6%

Planet Labs PBC held $415.1M in cash as of Q2 2027; long-term debt is not reported for that period.

Shares Outstanding
Diluted avg 360M

Planet Labs PBC had a weighted average of 360M diluted shares in Q2 2027; the shares outstanding count is not reported for that period.

Dividends Per Share

Not reported for Q2 2027.

Margins & Returns

Gross Margin
56.5%
YoY-1.0pp
QoQ+3.0pp
5Y change+21.7pp

Planet Labs PBC's gross margin was 56.5% in Q2 2027, indicating the percentage of revenue retained after direct costs. This is down 1.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.0 percentage points.

Operating Margin
-11.6%
YoY+12.8pp
QoQ+25.4pp
5Y change-1.2pp

Planet Labs PBC's operating margin was -11.6% in Q2 2027, reflecting core business profitability. This is up 12.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 25.4 percentage points.

Net Margin
-8.1%
YoY+22.7pp
5Y change-7.3pp

Planet Labs PBC's net profit margin was -8.1% in Q2 2027, showing the share of revenue converted to profit. This is up 22.7 percentage points from the same quarter a year earlier.

Return on Equity
-1.7%
YoY+3.5pp
QoQ+29.6pp

Planet Labs PBC's ROE was -1.7% in Q2 2027, measuring profit generated per dollar of shareholder equity. This is up 3.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 29.6 percentage points.

Capital Allocation

R&D Spending
$35.2M
YoY+45.5%
QoQ+5.2%
5Y CAGR+23.1%

Planet Labs PBC invested $35.2M in research and development in Q2 2027. This represents an increase of 45.5% from the same quarter a year earlier. Against the prior quarter it is up 5.2%.

Capital Expenditures
$27.3M
YoY+34.8%
QoQ+58.0%
5Y CAGR+66.3%

Planet Labs PBC invested $27.3M in capex in Q2 2027, funding long-term assets and infrastructure. This represents an increase of 34.8% from the same quarter a year earlier. Against the prior quarter it is up 58.0%.

Share Buybacks

Not reported for Q2 2027.

PL Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PL quarterly income statement
MetricQ2'2710-QQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-Q
Revenue$116.1M+58.1%$94.2M+42.1%$86.8M+41.1%$81.3M+32.6%$73.4M+20.1%$66.3M+9.6%$61.6M+4.6%$61.3M+10.6%
Cost of Revenue$50.4M+62.0%$43.7M+47.5%$39.8M+70.5%$34.7M+46.0%$31.1M+8.1%$29.7M+3.1%$23.3M-11.5%$23.7M-19.1%
Gross Profit$65.6M+55.3%$50.4M+37.7%$47.0M+23.1%$46.6M+24.2%$42.3M+30.8%$36.6M+15.5%$38.2M+17.7%$37.5M+44.1%
R&D Expenses$35.2M+45.5%$33.4M+44.8%$32.2M+40.3%$27.3M+8.4%$24.2M-11.4%$23.1M-9.8%$23.0M-19.2%$25.2M-23.6%
SG&A Expenses$22.5M+21.6%$29.1M+45.5%$30.8M+62.7%$18.8M+3.9%$18.5M-11.5%$20.0M+4.2%$18.9M+5.9%$18.1M-9.9%
Operating Income-$13.5M+24.8%-$34.9M-53.2%-$36.0M-85.9%-$18.3M+18.9%-$18.0M+54.6%-$22.8M+34.1%-$19.4M+42.9%-$22.6M+52.8%
EBITDA-$4.0M+50.3%-$23.7M-102.7%-$24.4M-172.7%-$9.1M+30.3%-$8.1M+70.1%-$11.7M+45.6%-$8.9M+58.3%-$13.1M+62.2%
Interest Expense$1.4M+353.9%$1.4M+189.8%$1.6M$1.0M+268.2%$317K$499KN/A$277K
Income Tax$733K+47.5%$1.0M+8.9%$2.4M+123.2%$784K+3036.0%$497K-44.6%$928K+110.0%$1.1M+355.5%$25K-93.0%
Net Income-$9.4M+58.6%-$138.9M-999.7%-$152.5M-333.7%-$59.2M-194.7%-$22.6M+41.6%-$12.6M+56.9%-$35.2M-16.8%-$20.1M+47.2%
EPS (Basic)-$0.03+57.1%-$0.40-900.0%-$0.49-308.3%-$0.19-171.4%-$0.07+46.2%-$0.04+60.0%-$0.12-20.0%-$0.07+46.2%
EPS (Diluted)-$0.03+57.1%-$0.40-900.0%-$0.49-308.3%-$0.19-171.4%-$0.07+46.2%-$0.04+60.0%-$0.12-20.0%-$0.07+46.2%
Diluted Shares (Avg)360M+18.2%346M+15.1%N/A309M+5.4%304M+4.7%300M+4.2%N/A293M+3.2%

PL Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PL quarterly balance sheet
MetricQ2'2710-QQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-Q
Total Assets$1.4B+105.5%$1.3B+90.1%$1.1B+80.8%$1.1B+75.4%$696.4M+5.8%$658.4M-2.4%$633.8M-9.7%$630.8M-11.6%
Current Assets$998.8M+181.0%$849.0M+161.4%$775.4M+156.6%$754.1M+150.1%$355.5M+8.8%$324.8M-6.1%$302.2M-18.4%$301.6M-22.2%
Cash & Equivalents$415.1M+129.2%$368.1M+175.8%$229.4M+94.4%$443.3M+219.0%$181.1M+22.1%$133.5M+24.3%$118.0M+40.8%$139.0M+36.9%
Short-Term Investments$450.3M+397.8%$362.7M+291.6%$410.6M+294.8%$234.0M+126.6%$90.5M-10.5%$92.6M-44.9%$104.0M-51.6%$103.3M-51.6%
Inventory$8.9M$9.3M$6.1MN/AN/AN/A$0N/A
Accounts Receivable$59.9M+16.0%$61.6M-17.5%$83.5M+49.6%$46.3M+19.2%$51.6M+17.5%$74.7M+93.8%$55.8M+28.9%$38.9M-13.9%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$142.7M+2.9%$143.1M+3.3%$143.5M+5.2%$139.0M+1.1%$138.6M+1.0%$138.5M+1.0%$136.3M+0.1%$137.4M+1.3%
Total Liabilities$866.6M+232.4%$807.7M+278.2%$957.3M+397.2%$756.5M+355.3%$260.7M+40.9%$213.6M+22.6%$192.5M+4.6%$166.2M-7.6%
Current Liabilities$351.3M+72.6%$302.5M+95.8%$469.5M+230.4%$188.6M+46.1%$203.5M+45.7%$154.6M+22.3%$142.1M+4.0%$129.1M-1.6%
Non-Current Liabilities$515.3M+800.2%$505.2M+755.7%$487.8M+867.2%$567.9M+1431.8%$57.2M+26.0%$59.0M+23.2%$50.4M+6.6%$37.1M-24.0%
Total Equity$564.4M+29.5%$443.7M-0.2%$188.4M-57.3%$349.6M-24.8%$435.7M-7.9%$444.8M-11.1%$441.3M-14.8%$464.6M-12.9%
Retained Earnings-$1.6B-29.1%-$1.6B-30.7%-$1.4B-20.5%-$1.3B-11.1%-$1.2B-7.9%-$1.2B-9.6%-$1.2B-11.4%-$1.2B-11.3%

Not reported in any period shown, so not listed: Long-Term Debt.

PL Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PL quarterly cash flow statement
MetricQ2'2710-QQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-Q
Operating Cash Flow$52.9M-21.9%$15.4M-11.0%$20.6M+428.0%$28.6M+601.5%$67.8M+962.5%$17.3M+503.7%-$6.3M+7.9%$4.1M+117.8%
Depreciation & Amortization$9.5M-4.0%$11.2M+1.0%$10.2M+10.1%$9.2M-3.2%$9.9M-21.4%$11.1M-15.4%$9.3M-20.1%$9.5M-28.0%
Stock-Based Compensation$17.1M+26.8%$16.5M+31.2%N/A$13.5M+13.9%$13.5M+16.3%$12.5M-4.1%N/A$11.8M-6.1%
Capital Expenditures$27.3M+34.8%$17.3M+113.2%$21.6M+86.2%$26.7M+249.8%$20.3M+34.2%$8.1M-18.3%$11.6M+30.3%$7.6M+3.5%
Free Cash Flow$25.6M-46.1%-$1.9M-120.3%-$951K+94.7%$1.9M+153.1%$47.5M+306.6%$9.2M+164.8%-$17.9M-13.7%-$3.6M+88.2%
Investing Cash Flow-$117.4M-504.1%$30.4M+1647.9%-$204.4M-1456.3%-$171.0M-1500.3%-$19.4M-137.9%$1.7M-94.3%-$13.1M-37.5%-$10.7M-152.7%
Financing Cash Flow$113.8M+11434.9%$95.2M+1139.4%-$31.0M-13221.9%$398.3M+4006.0%-$1.0M+63.2%-$9.2M-285.6%-$233K+81.2%-$10.2M-423.7%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

PL Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PL quarterly financial ratios
MetricQ2'2710-QQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-Q
Gross Margin56.5%-1.0pp53.5%-1.7pp54.2%-7.9pp57.3%-3.9pp57.6%+4.7pp55.2%+2.8pp62.1%+6.9pp61.2%+14.2pp
Operating Margin-11.6%+12.8pp-37.1%-2.7pp-41.5%-10.0pp-22.6%+14.3pp-24.5%+40.3pp-34.4%+22.8pp-31.5%+26.2pp-36.9%+49.5pp
Net Margin-8.1%+22.7pp-147.5%-175.6%-72.8%-40.1pp-30.8%+32.5pp-19.1%+29.4pp-57.1%-6.0pp-32.8%+35.8pp
Return on Equity-1.7%+3.5pp-31.3%-28.5pp-80.9%-72.9pp-16.9%-12.6pp-5.2%+3.0pp-2.8%+3.0pp-8.0%-2.2pp-4.3%+2.8pp
Return on Assets-0.7%+2.6pp-11.1%-9.2pp-13.3%-7.8pp-5.3%-2.2pp-3.2%+2.6pp-1.9%+2.4pp-5.5%-1.3pp-3.2%+2.1pp
Current Ratio2.84+1.1x2.81+0.7x1.65-0.5x4.00+1.7x1.75-0.6x2.10-0.6x2.13-0.6x2.34-0.6x
Debt-to-Equity1.54+0.9x1.82+1.3x5.08+4.6x2.16+1.8x0.60+0.2x0.48+0.1x0.44+0.1x0.360.0x
Asset Turnover0.080.0x0.080.0x0.080.0x0.070.0x0.110.0x0.100.0x0.100.0x0.100.0x
FCF Margin22.1%-42.6pp-2.0%-15.9pp-1.1%+28.0pp2.3%+8.1pp64.7%+102.3pp13.9%+37.5pp-29.1%-2.3pp-5.8%+48.8pp

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Planet Labs PBC PL FY2026 $307.7M -$246.9M -80.2% $6.4B 59/100
VSE Corp VSEC FY2025 $1.1B $11.7M 1.1% $4.7B 57/100
AAR Corp. AIR FY2026 $3.3B $187.7M 5.7% $4.1B 41/100
Hexcel Corporation HXL FY2025 $1.9B $109.4M 5.8% $6.5B 52/100
Mercury Systems Inc. MRCY FY2026 $983.6M -$29.7M -3.0% $5.2B 51/100

Frequently Asked Questions

What is Planet Labs PBC's annual revenue?

Planet Labs PBC (PL) reported $307.7M in total revenue for fiscal year 2026. This represents a 25.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Planet Labs PBC's revenue growing?

Planet Labs PBC (PL) revenue grew by 25.9% year-over-year, from $244.4M to $307.7M in fiscal year 2026.

Is Planet Labs PBC profitable?

No, Planet Labs PBC (PL) reported a net income of -$246.9M in fiscal year 2026, with a net profit margin of -80.2%.

Planet Labs PBC (PL) reported diluted earnings per share of -$0.80 for fiscal year 2026. This represents a -90.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Planet Labs PBC (PL) had EBITDA of -$53.2M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

Planet Labs PBC (PL) had a gross margin of 56.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

Planet Labs PBC (PL) had an operating margin of -30.9% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

Planet Labs PBC (PL) had a net profit margin of -80.2% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Planet Labs PBC (PL) has a return on equity of -131.0% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

Planet Labs PBC (PL) generated $57.6M in free cash flow during fiscal year 2026. This represents a 198.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Planet Labs PBC (PL) generated $134.4M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

Planet Labs PBC (PL) had $1.1B in total assets as of fiscal year 2026, including both current and long-term assets.

Planet Labs PBC (PL) invested $76.7M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Planet Labs PBC (PL) invested $106.7M in research and development during fiscal year 2026.

Planet Labs PBC (PL) had a current ratio of 1.65 as of fiscal year 2026, which is generally considered healthy.

Planet Labs PBC (PL) had a debt-to-equity ratio of 5.08 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

Planet Labs PBC (PL) had a return on assets of -21.6% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

Planet Labs PBC (PL) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to July 31, 2026). The market capitalization is $6.4B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Planet Labs PBC (PL) trades at 16.8x sales, its market capitalization divided by revenue of $378.3M revenue, trailing 12 months to July 31, 2026. The market capitalization is $6.4B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Planet Labs PBC (PL) has an Altman Z-Score of 2.53, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Planet Labs PBC (PL) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Planet Labs PBC (PL) reported a net loss of $246.9M while generating $134.4M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Planet Labs PBC (PL) reported an operating loss of $95.1M against $3.4M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Planet Labs PBC (PL) scores 59 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top